Compare

BriaCell Therapeutics Corp. vs Immunic, Inc. vs Rein Therapeutics, Inc. vs Kiora Pharmaceuticals Inc

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearBriaCell Therapeutics Corp.
BCTX
Immunic, Inc.
IMUX
Rein Therapeutics, Inc.
RNTX
Kiora Pharmaceuticals Inc
KPRX
Year ended2026-07-312025-12-312025-12-312025-12-31
Revenuen/an/a$0$0
Revenue growth (YoY)n/an/an/a-100.0%
Gross marginn/an/an/an/a
Operating marginn/an/an/an/a
Net marginn/an/an/an/a
Net income-$34.90M-$97.17M-$49.87M-$10.84M
EPS (Diluted)-$6.97-$0.62-$1.96-$2.64
Operating cash flow-$28.65M-$85.81M-$19.36M-$9.96M
Free cash flow-$28.78M-$85.97Mn/a-$10.07M
Cash & equivalents$9.85M$15.48M$3.21M$8.70M
Total assets$23.58M$24.05M$24.16M$24.25M
Total liabilitiesn/a$30.73M$7.24M$8.13M
Shareholders' equity$15.56M-$6.67M$16.92M$16.13M
Return on year-end equity-224.3%n/a-294.8%-67.2%
Shares outstanding8.71M90.15M27.55M3.76M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearBriaCell Therapeutics Corp.Immunic, Inc.Rein Therapeutics, Inc.Kiora Pharmaceuticals Inc
Latestn/an/a$0
Ended 2025-12-31
$0
Ended 2025-12-31
1 year earliern/an/a$0
Ended 2024-12-31
$16.02M
Ended 2024-12-31
2 years earliern/an/a$0
Ended 2023-12-31
$0
Ended 2023-12-31
3 years earliern/an/a$0
Ended 2022-12-31
n/a
4 years earliern/an/a$0
Ended 2021-12-31
$0
Ended 2021-12-31